News & Events

Tufts MC participates in COVID-19 vaccine clinical trial

Researchers at Tufts Medical Center, in partnership with Tufts Clinical and Translational Science Institute (CTSI) are seeking healthy volunteers for a COVID-19 vaccine study.

The vaccine, made by AstraZeneca, will enroll 30,000 people worldwide, in the study. The study will see how safe the investigational vaccine is and how well it works.

Participants in the study must:

  •  Be 18 years of age or older
  • Be in good or stable health (you may have an underlying medical condition and still take part, if your disease is stable)
  • Be at increased risk of getting COVID-19 (health care workers are considered at increased risk)
  • Not have a previous confirmed diagnosis of COVID-19

Participants will be randomly assigned (by chance) to receive 2 injections of either the investigational vaccine or a placebo. A placebo looks like the investigational vaccine but contains no active vaccine. There is twice as much chance of receiving the investigational vaccine than receiving the placebo. 

If you take part, you will be in the study for approximately two years and will require up to 10 visits to the study office at Tufts Medical Center. Additional visits may be required if you develop symptoms of COVID-19 during the study.  Your health will be monitored carefully by a team of doctors and nurses throughout the study. The study injections, health assessments and medical tests related to the study will be provided at no cost to you. 

Contact the study team today if you are interested in joining this COVID-19 Vaccine study or if you want more information. By contacting us, you are under no obligation to take part in the study. 

Saba Mostafavi – 617-935-1044
Bipin Malla – 865-360-0592